It’s a tough pill to swallow for any athlete, and for Jordan Westburg of the Baltimore Orioles, the news of season-ending elbow surgery is a particularly bitter one. Personally, I think it’s always disheartening to see a player’s season cut short, especially when it’s due to a persistent injury that ultimately requires a drastic measure like surgery. Westburg, who was already on the 60-day injured list, will now miss the entirety of the 2026 campaign. This development, while perhaps not entirely unexpected given his prior diagnosis of a partial UCL tear in February, still represents a significant blow.
The decision to pursue non-surgical options initially, including a platelet-rich plasma injection, is a common strategy in professional sports. From my perspective, it's a pragmatic approach aimed at avoiding lengthy recovery periods. The hope is always that the conservative treatment will be enough to get the player back on the field sooner. However, as we've seen in Westburg's case, sometimes the injury proves too stubborn, and surgery becomes the inevitable, albeit delayed, solution. What makes this particularly fascinating is the inherent gamble involved in these decisions; teams and players weigh the potential for a quicker return against the risk of the injury worsening or requiring surgery down the line anyway.
While pitchers often face a year-long rehabilitation for UCL surgeries, position players like Westburg can typically return to play more quickly. In my opinion, this offers a glimmer of hope that he could be ready for the start of the 2027 season, which, in a way, negates some of the lost time compared to if he had opted for surgery back in February. Still, the mental toll of missing an entire year, especially after a promising breakout in 2024, must be immense. One thing that immediately stands out is the unfortunate pattern of injuries that has plagued Westburg’s young career. A hand fracture limited his 2024 season, and he then dealt with hamstring and ankle issues in 2025. Now, this elbow surgery sidelines him for the entire 2026 season. It’s a stark reminder of the physical demands of the game and the unpredictable nature of athletic careers.
Beyond the individual impact, Westburg’s absence is another significant piece in the Orioles’ injury puzzle. He joins a lengthy list of players currently sidelined, including other key position players like Jackson Holliday, Dylan Beavers, Ryan Mountcastle, and Heston Kjerstad. This widespread attrition has undoubtedly forced the Orioles to scramble, relying on backup plans and less experienced players to fill crucial infield roles. What many people don't realize is how much depth and adaptability are tested when multiple starters go down. We've seen players like Coby Mayo and Jeremiah Jackson stepping in at third and second base, respectively, but their offensive production has been, to put it mildly, subpar. This situation highlights the critical importance of a strong farm system and a robust organizational depth chart, especially for a team with championship aspirations.
Despite the mounting injuries and a slow start to the season, the Orioles find themselves in a surprisingly salvageable position. In my opinion, the parity within the American League this year means that even a team with a losing record can remain in playoff contention. However, the fact that they are currently just a game and a half out of a playoff spot speaks volumes about the league's overall performance rather than their own dominance. The team will need other players to step up significantly in Westburg's absence, and if the current infielders can't elevate their game, I wouldn't be surprised to see the Orioles actively seeking external help before the trade deadline. This entire situation serves as a compelling case study in the resilience required in professional sports, both for the individual athlete battling through adversity and for the team navigating the challenges of a depleted roster.
